Paul Ginocchio - 26 May 2022 Form 4 Insider Report for Augmedix, Inc.

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Todd Holvick, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
26 May 2022
Net transactions value
+$35,920
Form type
4
Filing time
27 May 2022, 20:45:10 UTC
Previous filing
11 Mar 2022
Next filing
15 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUGX Common Stock Purchase $31,840 +16,000 +20% $1.99 98,000 26 May 2022 Direct F1
transaction AUGX Common Stock Purchase $4,080 +2,000 +2% $2.04 100,000 27 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades ranging from $1.85 to $2.09. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.